Table 2.
α2-Heremans-schmid glycoprotein levels (g/L) with respect to disease characteristics
| IBD | UC | CD | P value | |
| Extent (UC) | ||||
| Proctitis | - | 0.35 ± 0.1 | - | > 0.05 |
| Left-sided colitis | - | 0.34 ± 0.12 | - | |
| Pancolitis | - | 0.35 ± 0.10 | - | |
| Location (CD) | ||||
| Upper GI | - | - | 0.29 ± 0.09 | > 0.05 |
| Ileum | - | - | 0.32 ± 0.08 | |
| Colon | - | - | 0.31 ± 0.09 | |
| Ileocolon | - | - | 0.29 ± 0.07 | |
| Behavior (CD) | ||||
| NS/NP (a) | - | - | 0.33 ± 0.07 | a vs b: < 0.01 |
| Stricturing (b) | - | - | 0.26 ± 0.07 | a vs c: < 0.001 |
| Penetrating (c) | - | - | 0.26 ± 0.06 | b vs c: > 0.05 |
| Extraintestinal manifestations | ||||
| None | 0.33 ± 0.01 | 0.33 ± 0.09 | 0.33 ± 0.07 | > 0.05 |
| ≥ 1 | 0.32 ± 0.01 | 0.36 ± 0.1 | 0.30 ± 0.08 |
IBD: Inflammatory bowel disease; UC: Ulcerative colitis; CD: Crohn’s disease; GI: Gastrointestinal; NS/NP: Non stricturing/Non penetrating.